|Title:||High purity lipopeptides|
|Abstract:||The invention discloses highly purified daptomycin and to pharmaceutical compositions comprising this compound. The invention discloses a method of purifying daptomycin comprising the sequential steps of anion exchange chromatography, hydrophobic interaction chromatography and anion exchange chromatography. The invention also discloses a method of purifying daptomycin by modified buffer enhanced anion exchange chromatography. The invention also discloses an improved method for producing daptomycin by fermentation of Streptomyces roseosporus. The invention also discloses high pressure liquid chromatography methods for analysis of daptomycin purity. The invention also discloses lipopeptide micelles and methods of making the micelles. The invention also discloses methods of using lipopeptide micelles for purifying lipopeptide antibiotics, such as daptomycin. The invention also discloses using lipopeptide micelles therapeutically.|
|Inventor(s):||Kelleher; Thomas (Weston, MA), Lai; Jan-Ji (Westborough, MA), DeCourcey; Joseph P. (Charlestown, MA), Lynch; Paul (Arlington, MA), Zenoni; Maurizio (Milan, IT), Tagliani; Auro (Pavia, IT)|
|Assignee:||Cubist Pharmaceuticals, Inc. (Lexington, MA)|
Patent Claim Types:|
see list of patent claims
|Composition; Process; Formulation; Use;|
Back Citations: 28th percentile
Forward Citations: 8th percentile
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.